On the contrary, Leng et al. [20] found that EA can improve obesity and reduce the potential risk of type 2 diabetes via hypothalamic Tsc1 promoter demethylation and by inhibiting the activity of mTORC1 signaling pathway. The gene discussed is TSC1; the disease is obesity due to melanocortin 4 receptor deficiency.